This finding highlights the neuroprotective activity of PDG, which decreases neuroinflammation by modulating the TLR4/NF-κB pathway, thus reducing cognitive dysfunction in AD mice, suggesting that PDG is a potential drug for AD treatment. This evidence concerns the gene PHGDH and Alzheimer disease.